Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115121535 | 11512153 | 5 | F | 20160831 | 20150916 | 20160902 | EXP | CA-ROCHE-1633524 | ROCHE | 54.00 | YR | F | Y | 0.00000 | 20160902 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115121535 | 11512153 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 125276 | |||||||||||
| 115121535 | 11512153 | 2 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 0 | |||||||||||
| 115121535 | 11512153 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | U | 0 | ||||||||||
| 115121535 | 11512153 | 4 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
| 115121535 | 11512153 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 115121535 | 11512153 | 6 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115121535 | 11512153 | 1 | Rheumatoid arthritis |
| 115121535 | 11512153 | 2 | Rheumatoid arthritis |
| 115121535 | 11512153 | 3 | Rheumatoid arthritis |
| 115121535 | 11512153 | 4 | Rheumatoid arthritis |
| 115121535 | 11512153 | 5 | Rheumatoid arthritis |
| 115121535 | 11512153 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115121535 | 11512153 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115121535 | 11512153 | Alopecia | |
| 115121535 | 11512153 | C-reactive protein increased | |
| 115121535 | 11512153 | Drug dependence | |
| 115121535 | 11512153 | Drug ineffective | |
| 115121535 | 11512153 | Drug intolerance | |
| 115121535 | 11512153 | Ecchymosis | |
| 115121535 | 11512153 | Impaired work ability | |
| 115121535 | 11512153 | Joint range of motion decreased | |
| 115121535 | 11512153 | Liver disorder | |
| 115121535 | 11512153 | Lung disorder | |
| 115121535 | 11512153 | Red blood cell sedimentation rate increased | |
| 115121535 | 11512153 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115121535 | 11512153 | 1 | 20150914 | 0 |